Hunter Chen

This inventor holds 25 USPTO granted patents and 14 published patent applications and 10 EPO patents, primarily in Biopharmaceutical Formulations. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hunter Chen. Retrieved from https://idiyas.com/inventor/hunter-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 14)

% Patents Active = 96.0

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 64(Granted Patents)

Location History:

Tarrytown, NY (US) (2023)
New York, NY (US) (2021 - 2024)

Company Filing History:

23 out of 1,482

Regeneron Pharmaceuticals, Inc.

patents

2 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2021-2026

Loading Chart...

Areas of Expertise:

Sustained Release

Non-Aqueous Emulsions

Anti-VEGF

Protein Compositions

Hydrogels

Microgels

Protein Formulation

Deglycosylation

Polymer Microparticles

Electrophoresis

Release Kinetics

Protein Encapsulation

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12667603 - Sustained release formulations using non-aqueous emulsions (2026-06-30),

2. 12480955 - DEGLYCOSYLATION METHODS FOR ELECTROPHORESIS OF GLYCOSYLATED PROTEINS (2025-11-25),

3. 12396952 - Tuning of release kinetics in hydrogels (2025-08-26),

4. 12350374 - Fabrication of protein-encapsulating microgels (2025-07-08),

5. 12338274 - Anti-VEGF protein compositions and methods for producing the same (2025-06-24),

6. 12319728 - Anti-VEGF protein compositions and methods for producing the same (2025-06-03),

7. 12239687 - Sustained release formulations using non-aqueous membrane emulsification (2025-03-04),

8. 12054532 - Anti-VEGF protein compositions and methods for producing the same (2024-08-06),

9. 12036280 - High concentration protein formulation (2024-07-16),

10. 12012445 - Anti-VEGF protein compositions and methods for producing the same (2024-06-18),

11. 12012444 - Anti-VEGF protein compositions and methods for producing the same (2024-06-18),

12. 11958894 - Anti-VEGF protein compositions and methods for producing the same (2024-04-16),

13. 11951216 - Polymer protein microparticles (2024-04-09),

14. 11835527 - Deglycosylation methods for electrophoresis of glycosylated proteins (2023-12-05),

15. 11753459 - Anti-VEGF protein compositions and methods for producing the same (2023-09-12),

Title: The Innovative Journey of Hunter Chen

Introduction

Hunter Chen is a renowned inventor based in New York, NY, whose impressive portfolio boasts 19 patents. His work primarily focuses on advanced pharmaceutical formulations, pushing the boundaries of innovation in drug delivery systems.

Latest Patents

Among his latest patents, Hunter has developed groundbreaking formulations utilizing non-aqueous membrane emulsification methods for producing polymeric and polymer-coated microparticles. This innovative technique allows for the creation of sustained release or controlled release microparticles. By combining micronized protein powder and polymer into a hydrocarbon solvent, he formulates a non-aqueous solution. The process includes agitating this solution to create a suspension, which is then infused through a porous membrane into a continuous phase comprising a fluorocarbon liquid and fluorosurfactant, ultimately forming a hydrocarbon-in-fluorocarbon emulsion. After the removal of solvents, the microparticles are collected for further use. Additionally, his work on anti-VEGF protein compositions showcases his expertise in biopharmaceuticals, providing methods for producing such vital compositions.

Career Highlights

Hunter Chen has made significant contributions to the field of pharmaceuticals, particularly during his tenure at Regeneron Pharmaceuticals, Inc. His innovative spirit is evident through his numerous patents that focus on creating effective drug delivery mechanisms.

Collaborations

Throughout his career, Hunter has collaborated with esteemed colleagues, including Shunhai Wang and Amardeep Singh Bhupender Bhalla. These professional relationships have undoubtedly enriched his work, fostering a collaborative environment that promotes creativity and technological advancement.

Conclusion

Hunter Chen’s innovations reflect a deep commitment to enhancing pharmaceutical formulations through inventive methodologies. His 19 patents demonstrate not only his creativity but also his dedication to improving healthcare outcomes. As a leading inventor in his field, Hunter continues to pave the way for future advancements in drug delivery systems.

Profile summary based on public USPTO records.